المنشورات طباعة Gudsoorkar P, Hanna PE, Meena P, Karam S. Oncohypertension: Unraveling the Link Between Cancer and Hypertension. Adv Kidney Dis Health. 2026 Jul 6 Epub 2026 July 06 View PubMed Kelly A, Sharma S, Mamlouk O, Hassanein M, Chowdhury R, Gupta S, Troung H, Bonilla M, Kalra K, Wanchoo R, Pariswala T, Turcotte AE, Zaveri I, Dernell C, Ibrahim M, Patel M, Eskander SS, Gudsoorkar P, Jhaveri KD, Perazella MA, Hanna PE. Nephrotoxicity of conventional chemotherapeutics: part 1-platinum compounds and antimetabolite agents. Nephrol Dial Transplant. 2026 May 29; 41 (6):1011-1022 View PubMed Kelly A, Sharma S, Mamlouk O, Hassanein M, Chowdhury R, Gupta S, Truong H, Bonilla M, Kalra K, Wanchoo R, Pariswala T, Turcotte AE, Zaveri I, Dernell C, Ibrahim M, Patel M, Eskander SS, Gudsoorkar P, Jhaveri KD, Perazella MA, Hanna PE. Nephrotoxicity of conventional chemotherapeutics: part II-non-platinum agents and miscellaneous nephrotoxic drugs. Nephrol Dial Transplant. 2026 Apr 30; 41 (5):828-838 View PubMed Sarmad A, Gholizadeh Ghozloujeh Z, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, Mathew R, Ahmad M, Mohammed A, Siddiqui S, Abdipour A, Norouzi S. Cardiovascular involvement in ANCA-associated vasculitis. Nephrol Dial Transplant. 2025 Nov 26; 40 (12):2256-2267 View PubMed Lyu J, Specht K, Seiglie JA, Ouyang T, Mistry K, Seethapathy H, Zubiri L, Khor SY, Hanna PE, Cao A, Moreno D, Mejia SM, Gupta S, Sise ME. Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An inverse probability treatment weighting analysis. Cancer Lett. 2025 Nov 01; 632:217958. Epub 2025 Jul 28. View PubMed Moreno D, Hanna PE, Mistry K, Heidari P, Sise ME, Seethapathy H. Clinical Implications of Striated Nephrogram in Patients Receiving Immune Checkpoint Inhibitors for Cancer. Kidney Med. 2025 Aug; 7 (8):101038 Epub 2025 May 29 View PubMed Lyu J, Mantz L, Katz-Agranov NS, Ouyang T, Hanna PE, Mejia SM, Moreno D, Lee M, Cao A, Dinulos JE, Cosar D, Shaker M, Shah SJ, Gainor JF, Temel JS, Lei M, Inker LA, Fintelmann FJ, Sise ME. Sarcopenia, Elevated Body Mass Index, and Platinum-Associated Adverse Events in Patients With Lung Cancer. J Natl Compr Canc Netw. 2025 Jul 30; 23 (9):393-400 Epub 2025 July 30 View PubMed Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S. Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer. Kidney Int Rep. 2024 Jun; 9 (6):1897-1902 Epub 2024 Mar 13 View PubMed Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, Strohbehn I, Moreno D, Harden D, Dinulos JE, Cosar D, Seethapathy H, Gainor JF, Shah SJ, Gupta S, Leaf DE, Fintelmann FJ, Sise ME. Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer. J Cachexia Sarcopenia Muscle. 2024 Jun; 15 (3):1187-1198 Epub 2024 Apr 22 View PubMed Hanna PE, Chowdhury R, Solhjou Z, Gupta S, Jhaveri KD. Challenges for optimal care in onconephrology. Nephrol Dial Transplant. 2024 Jan 31; 39(2):167-169. View PubMed Wang Q, Seethapathy R, Ouyang T, Strohbehn IA, Katz-Agranov N, Hanna P, Madken M, Seethapathy H, Gupta S, Heller HM, Wszolek M, Steele D, Klepeis VE, Rennke H, Sise ME. Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder Substitution. Kidney Int Rep. 2023 Dec; 8 (12):2833-2837 Epub 2023 Sept 17 View PubMed Hanna PE, Strohbehn IA, Moreno D, Harden D, Seethapathy R, Sawtell R, Wang Q, Ouyang T, Katz-Agranov N, Dinulos J, Wander SA, Gupta S, Sise ME. Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer. NPJ Breast Cancer. 2023 Aug 19; 9 (1):70 View PubMed Gupta S, Hanna PE, Ouyang T, Yamada KS, Sawtell R, Wang Q, Katz-Agranov N, Feghali L, Krasner CN, Bouberhan S, Castro CM, Sise ME. Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors. J Natl Cancer Inst. 2023 Jul 6; 115 (7):831-837 View PubMed Hanna PE, Wang Q, Strohbehn IA, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME. Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer. JAMA Netw Open. 2023 Jul 3; 6 (7):e2321715 Epub 2023 July 03 View PubMed Vergara-Cadavid J, Johnson PC, Kim HT, Yi A, Sise ME, Leaf DE, Hanna PE, Ho VT, Cutler CS, Antin JH, Gooptu M, Kelkar AH, Wells SL, Nikiforow S, Koreth J, Romee R, Soiffer RJ, Shapiro RM, Gupta S. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023 Jul; 29 (7):455.e1-455.e9 Epub 2023 Apr 02 View PubMed Tiu BC, Strohbehn IA, Zhao S, Ouyang T, Hanna P, Wang Q, Gupta S, Leaf DE, Reynolds KL, Sise ME. Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study. Oncologist. 2023 Jun 2; 28 (6):e379-e390 View PubMed Wang Q, Strohbehn IA, Zhao S, Seethapathy H, Strohbehn SD, Hanna P, Lee M, Fadden R, Sullivan RJ, Boland GM, Reynolds KL, Sise ME. Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma. Kidney Int Rep. 2022 Nov; 7 (11):2517-2521 Epub 2022 Sept 08 View PubMed Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 Oct; 102(4):930-935. Epub 2022 Aug 11. View PubMed PST-20603109 الصفحة الرئيسية المنشورات